♟️ Tuesday 27 October 2026 Tue, 27 Oct 2026

Cygnus Metals has completed its acquisition by Central Asia Metals, transferring all Cygnus shares to the London-listed miner. Eligible shareholders received 0.06 new CAML shares for each Cygnus share, as Cygnus moves towards its final ASX delisting.

Venari Minerals has funded the next stage of its Red Mountain lithium project after raising $6.1 million, while drilling and permitting advance in Nevada. The company is also testing whether strontium and magnesium can add value beyond lithium carbonate, although commercial recovery remains unproven.

Vault Minerals delivered record FY2026 earnings, generated A$887.9 million in operating cash flow and ended the year debt-free before agreeing to combine with Genesis Minerals. The company now enters FY2027 fully exposed to spot gold prices, with its Leonora expansion and merger vote setting the next major tests.

Yandal Resources has extended its high-grade Arrakis discovery with a 20-metre intercept at 8.7g/t gold, including 3 metres at 52.8g/t. The exploration momentum comes with a pressing funding requirement, as the company ended September with $3.29 million in cash and plans an equity raising during the December quarter.

Norfolk Metals ended FY2026 with a sharply higher loss, just A$807,974 in cash and a material uncertainty over its ability to continue as a going concern. Its proposed Chilean copper expansion now depends on a minimum A$75 million capital raising, ASX re-compliance and completion of the Ciclón and Condor transactions.

Encounter Resources has grown its Aileron niobium resource by 54% to 120 million tonnes while moving the West Arunta project into mining lease, metallurgical and development work. The company also ended FY2026 with $26.9 million in cash and term deposits, but still has no Ore Reserves or operating revenue base.

Atlantic Lithium has received FIRB approval for Zhejiang Huayou Cobalt’s proposed A$292 million takeover, while Huayou has completed the transfer of Elevra’s Ghana project rights and agreed to fund up to US$66 million of remaining development obligations. The scheme still requires shareholder and court approval, with the first hearing scheduled for 5 November.

Jatcorp’s Q1 FY27 revenue fell 52.4% to A$4.66 million as a sharper seasonal downturn in China hit brand sales and OEM orders. Cash fell to A$3.727 million after A$2.145 million of operating outflows, leaving the company’s reported funding estimate at 1.7 quarters.

Global Lithium’s annual report captures a pivotal shift from lithium developer to takeover target, after the Manna-Nova integration study lifted estimated post-tax NPV8 to about A$946 million and cut funded pre-production capital by 59%. The proposed A$333 million Titan transaction offers shareholders cash value while leaving Manna’s development timetable subject to approvals, funding and execution.

Clean TeQ Water delivered a stronger FY26, with revenue up 71% to A$19.7 million, positive operating cash flow and a narrowed loss. The bigger shift is commercial: major water and critical-minerals contracts are moving into execution while the Rasp Mine agreement creates the company’s first recurring revenue stream.

The Takeovers Panel has ordered the forced sale of a substantial parcel of DGR Global shares after finding undisclosed associations and takeover-law breaches pushed related parties’ voting power as high as 45.43%. The orders also open the way for a takeover bid or scheme while imposing new controls on DGR’s board and major shareholders.

Azzuro Resources has outlined conceptual exploration targets of up to 55 million tonnes across two Mongolian copper projects, while a strategic investment from Kerry Resources Logistics provides fresh funding for the next phase. The quarter also delivered high-grade Red Hill drilling, but the targets remain short of Mineral Resource status and quarter-end cash was only A$1.615 million.

Elixir Energy has reported encouraging early flow results from its Lorelle-3H appraisal well while securing a $205 million strategic farmout with Beach Energy. The deal offers a four-year funding pathway, but the well’s post-soak performance and transaction completion remain important next tests.

OncoSil Medical delivered sharper commercial growth and a string of regulatory milestones in FY26, but the oncology device company remains heavily loss-making and dependent on future sales or fresh capital. Revenue rose 44% to $1.68 million while operating cash outflow reached $10.47 million.

WIN Metals has strengthened the funding position for its proposed Radio gold restart, while retaining a project that still requires approvals, further financing and a final investment decision. The preliminary study forecasts A$18.1 million of pre-tax NPV8 and 20.2koz of recovered gold, but the company ended September with only A$1.16 million in cash before the post-quarter Astral receipt.

Pacific Resources has reported encouraging high-grade results from Snowstorm and Dogwood, including 17.15 g/t gold and 1.10% copper. The exploration progress comes with a sharp funding constraint: cash fell to A$63,000 and the company is seeking further capital after taking a A$100,000 short-term loan from its chairman.

Immutep’s pivotal TACTI-004 lung cancer trial dominates a difficult FY26, with the failure widening the loss to A$79.3 million and triggering an impairment, cost cuts and a root cause review. The biotech retains A$68.9 million in cash, cash equivalents and term deposits, while its remaining investment case rests on IMP761 and selected efti studies.

PhosCo has expanded its Tunisian phosphate exploration story with new mineralisation, premium-grade concentrate results and a proposed A$1.4 million investment from engineering group STUDI International. The next test is whether the imminent scoping study can convert those technical gains into a credible development case.

European Lithium’s share and option schemes with Critical Metals Corp. are now effective after the Supreme Court of Western Australia’s orders were lodged with ASIC. EUR securities are expected to stop trading on the ASX, with implementation scheduled for 5 November and CRML shares due to begin trading on Nasdaq the following day.

Nova Eye Medical delivered 30% year-on-year sales growth in the September quarter, alongside positive operating cash flow and EBITDA. The company confirmed FY27 guidance, but is still seeking to replace a related-party funding facility carrying 15% interest.

Moab Minerals has secured four additional prospecting licences around its Manyoni uranium project in Tanzania, but ended September with just A$21,000 in cash. Planned testwork and 2027 drilling now depend on a conditional A$350,000 loan, further fundraising and creditor support.

White Energy has pivoted towards thermal and metallurgical coal, completed two acquisitions and raised $15 million after year end. But its FY2026 report records a $3.6 million normalised EBITDA loss, just $0.4 million in unrestricted cash and an auditor-highlighted material uncertainty over going concern.

Fleetwood enters FY27 with a stronger Community Solutions business, a $61.5 million net cash position and a plan to restore Building Solutions to profitability in the second half. The key tests are completing the Red Dog Village acquisition and proving its manufacturing reset can overcome a $8.7 million underlying loss.

Bounty Oil & Gas is pursuing a 2,322 km² deepwater block offshore Liberia, but the asset remains unlicensed and requires parliamentary approval before a production sharing contract can be executed. The proposed acquisition brings major exploration potential alongside substantial dilution, contingent payments and a fresh $3.5 million capital raise.